Trexquant Investment LP

Position in BHC — Bausch Health Companies Inc.

CIK 1633445 STAMFORD, CT

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,644,649

+$2,070,662 QoQ

Shares Held

536,440

+404.7% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#43

of 220 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $109,740,543 across 18 Drug Manufacturers - Specialty & Generic names. BHC ranks #11 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	676,544	$48,616,451
2	LQDA	Liquidia Corp	110,628	$8,820,370
3	HIMS	Hims & Hers Health, Inc.	233,191	$8,084,731
4	ELAN	Elanco Animal Health Inc	310,453	$7,640,248
5	AMLX	Amylyx Pharmaceuticals, Inc.	349,439	$6,275,924
6	PRGO	PERRIGO Co plc	542,952	$5,641,271
7	ANIP	Ani Pharmaceuticals Inc	56,093	$4,643,378
8	EBS	Emergent BioSolutions Inc.	447,858	$3,753,050

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,644,649	536,440	+404.7%	Shares	Sole	2026-08-14
2026-03-31	$573,987	106,294	-54.5%	Shares	Sole	2026-05-15
2025-12-31	$1,622,734	233,487	-43.3%	Shares	Sole	2026-02-17
2025-03-31	$2,662,016	411,440	+37.9%	Shares	Sole	2025-05-14
2024-12-31	$2,404,572	298,334	+155.4%	Shares	Sole	2025-02-12
2024-09-30	$953,104	116,802	+193.5%	Shares	Sole	2024-11-12
2024-06-30	$277,357	39,793	-32.7%	Shares	Sole	2024-08-13
2022-12-31	$371,173	59,104	-78.3%	Shares	Sole	2023-02-13
2022-06-30	$2,277,004	272,369	+306.4%	Shares	Sole	2022-08-11
2022-03-31	$1,531,338	67,017	+48.7%	Shares	Sole	2022-05-13
2021-09-30	$1,255,171	45,069	+77.1%	Shares	Sole	2021-11-12
2020-12-31	$529,464	25,455	-75.1%	Shares	Sole	2021-02-11
2020-03-31	$1,583,015	102,130	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.